Semochkin, S.V. 2024. Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma. Clinical Oncohematology. 16, 3 (Feb. 2024), 229–241. DOI:https://doi.org/10.21320/2500-2139-2023-16-3-229-241.